This Week in Biotech

This Week in Biotech

Filed under: drug treatment news articles

In March, the FDA sent MAP its decisions to reject the drug not based on efficacy or safety, but because of factors related to its manufacture, chemistry, or control of the treatment. With that now seeming resolved, MAP's drug, which it's licensed out …
Read more on Motley Fool

Two Biotech Beauties for the Long Run

Filed under: drug treatment news articles

Two Biotech Beauties for the Long Run. By JOHANNA BENNETT | MORE ARTICLES BY AUTHOR … At the annual meeting of the American Association for the Study of Liver Disease in Boston, the company released data showing that a pair of experimental drugs – GS …
Read more on Barron’s

McGinn missteps beckon crowd of potential rivals

Filed under: drug treatment news articles

Related. Most Popular Comments. Hide / Show comments. No comments have been posted to this article. Start the conversation … Given the ongoing problems with drug dealing and vagrancy downtown, it might not be a liability. Bruce Harrell. He easily won …
Read more on The Seattle Times